Global Non-invasive Cancer Diagnosis Market Insights and Forecast to 2031

Report ID: 1564571 | Published Date: Sep 2024 | No. of Page: 89 | Base Year: 2023 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Clinical Chemistry
        1.2.3 Immunochemistry/Immunoassay
        1.2.4 Molecular Diagnostics
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Blood Cancer
        1.3.3 Solid Tumors
        1.3.4 Breast Cancer
        1.3.5 Lung Cancer
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Non-invasive Cancer Diagnosis Market Perspective (2017-2028)
    2.2 Non-invasive Cancer Diagnosis Growth Trends by Region
        2.2.1 Non-invasive Cancer Diagnosis Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Non-invasive Cancer Diagnosis Historic Market Size by Region (2017-2022)
        2.2.3 Non-invasive Cancer Diagnosis Forecasted Market Size by Region (2023-2028)
    2.3 Non-invasive Cancer Diagnosis Market Dynamics
        2.3.1 Non-invasive Cancer Diagnosis Industry Trends
        2.3.2 Non-invasive Cancer Diagnosis Market Drivers
        2.3.3 Non-invasive Cancer Diagnosis Market Challenges
        2.3.4 Non-invasive Cancer Diagnosis Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Non-invasive Cancer Diagnosis Players by Revenue
        3.1.1 Global Top Non-invasive Cancer Diagnosis Players by Revenue (2017-2022)
        3.1.2 Global Non-invasive Cancer Diagnosis Revenue Market Share by Players (2017-2022)
    3.2 Global Non-invasive Cancer Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Non-invasive Cancer Diagnosis Revenue
    3.4 Global Non-invasive Cancer Diagnosis Market Concentration Ratio
        3.4.1 Global Non-invasive Cancer Diagnosis Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Non-invasive Cancer Diagnosis Revenue in 2021
    3.5 Non-invasive Cancer Diagnosis Key Players Head office and Area Served
    3.6 Key Players Non-invasive Cancer Diagnosis Product Solution and Service
    3.7 Date of Enter into Non-invasive Cancer Diagnosis Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Non-invasive Cancer Diagnosis Breakdown Data by Type
    4.1 Global Non-invasive Cancer Diagnosis Historic Market Size by Type (2017-2022)
    4.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Type (2023-2028)
5 Non-invasive Cancer Diagnosis Breakdown Data by Application
    5.1 Global Non-invasive Cancer Diagnosis Historic Market Size by Application (2017-2022)
    5.2 Global Non-invasive Cancer Diagnosis Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Non-invasive Cancer Diagnosis Market Size (2017-2028)
    6.2 North America Non-invasive Cancer Diagnosis Market Size by Type
        6.2.1 North America Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
        6.2.2 North America Non-invasive Cancer Diagnosis Market Size by Type (2023-2028)
        6.2.3 North America Non-invasive Cancer Diagnosis Market Share by Type (2017-2028)
    6.3 North America Non-invasive Cancer Diagnosis Market Size by Application
        6.3.1 North America Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
        6.3.2 North America Non-invasive Cancer Diagnosis Market Size by Application (2023-2028)
        6.3.3 North America Non-invasive Cancer Diagnosis Market Share by Application (2017-2028)
    6.4 North America Non-invasive Cancer Diagnosis Market Size by Country
        6.4.1 North America Non-invasive Cancer Diagnosis Market Size by Country (2017-2022)
        6.4.2 North America Non-invasive Cancer Diagnosis Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Non-invasive Cancer Diagnosis Market Size (2017-2028)
    7.2 Europe Non-invasive Cancer Diagnosis Market Size by Type
        7.2.1 Europe Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
        7.2.2 Europe Non-invasive Cancer Diagnosis Market Size by Type (2023-2028)
        7.2.3 Europe Non-invasive Cancer Diagnosis Market Share by Type (2017-2028)
    7.3 Europe Non-invasive Cancer Diagnosis Market Size by Application
        7.3.1 Europe Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
        7.3.2 Europe Non-invasive Cancer Diagnosis Market Size by Application (2023-2028)
        7.3.3 Europe Non-invasive Cancer Diagnosis Market Share by Application (2017-2028)
    7.4 Europe Non-invasive Cancer Diagnosis Market Size by Country
        7.4.1 Europe Non-invasive Cancer Diagnosis Market Size by Country (2017-2022)
        7.4.2 Europe Non-invasive Cancer Diagnosis Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Non-invasive Cancer Diagnosis Market Size (2017-2028)
    8.2 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Type
        8.2.1 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Non-invasive Cancer Diagnosis Market Share by Type (2017-2028)
    8.3 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Application
        8.3.1 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Non-invasive Cancer Diagnosis Market Share by Application (2017-2028)
    8.4 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region
        8.4.1 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Non-invasive Cancer Diagnosis Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Non-invasive Cancer Diagnosis Market Size (2017-2028)
    9.2 Latin America Non-invasive Cancer Diagnosis Market Size by Type
        9.2.1 Latin America Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
        9.2.2 Latin America Non-invasive Cancer Diagnosis Market Size by Type (2023-2028)
        9.2.3 Latin America Non-invasive Cancer Diagnosis Market Share by Type (2017-2028)
    9.3 Latin America Non-invasive Cancer Diagnosis Market Size by Application
        9.3.1 Latin America Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
        9.3.2 Latin America Non-invasive Cancer Diagnosis Market Size by Application (2023-2028)
        9.3.3 Latin America Non-invasive Cancer Diagnosis Market Share by Application (2017-2028)
    9.4 Latin America Non-invasive Cancer Diagnosis Market Size by Country
        9.4.1 Latin America Non-invasive Cancer Diagnosis Market Size by Country (2017-2022)
        9.4.2 Latin America Non-invasive Cancer Diagnosis Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Non-invasive Cancer Diagnosis Market Size (2017-2028)
    10.2 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Type
        10.2.1 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Non-invasive Cancer Diagnosis Market Share by Type (2017-2028)
    10.3 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Application
        10.3.1 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Non-invasive Cancer Diagnosis Market Share by Application (2017-2028)
    10.4 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country
        10.4.1 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Non-invasive Cancer Diagnosis Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Gen-Probe Inc.
        11.1.1 Gen-Probe Inc. Company Details
        11.1.2 Gen-Probe Inc. Business Overview
        11.1.3 Gen-Probe Inc. Non-invasive Cancer Diagnosis Introduction
        11.1.4 Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.1.5 Gen-Probe Inc. Recent Developments
    11.2 A&G Pharmaceutical
        11.2.1 A&G Pharmaceutical Company Details
        11.2.2 A&G Pharmaceutical Business Overview
        11.2.3 A&G Pharmaceutical Non-invasive Cancer Diagnosis Introduction
        11.2.4 A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.2.5 A&G Pharmaceutical Recent Developments
    11.3 Affymetrix Inc.
        11.3.1 Affymetrix Inc. Company Details
        11.3.2 Affymetrix Inc. Business Overview
        11.3.3 Affymetrix Inc. Non-invasive Cancer Diagnosis Introduction
        11.3.4 Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.3.5 Affymetrix Inc. Recent Developments
    11.4 Digene Corporation
        11.4.1 Digene Corporation Company Details
        11.4.2 Digene Corporation Business Overview
        11.4.3 Digene Corporation Non-invasive Cancer Diagnosis Introduction
        11.4.4 Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.4.5 Digene Corporation Recent Developments
    11.5 Quest Diagnostics Inc.
        11.5.1 Quest Diagnostics Inc. Company Details
        11.5.2 Quest Diagnostics Inc. Business Overview
        11.5.3 Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Introduction
        11.5.4 Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.5.5 Quest Diagnostics Inc. Recent Developments
    11.6 BioView Inc.
        11.6.1 BioView Inc. Company Details
        11.6.2 BioView Inc. Business Overview
        11.6.3 BioView Inc. Non-invasive Cancer Diagnosis Introduction
        11.6.4 BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.6.5 BioView Inc. Recent Developments
    11.7 LabCorp
        11.7.1 LabCorp Company Details
        11.7.2 LabCorp Business Overview
        11.7.3 LabCorp Non-invasive Cancer Diagnosis Introduction
        11.7.4 LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.7.5 LabCorp Recent Developments
    11.8 AVIVA Biosciences Corporation
        11.8.1 AVIVA Biosciences Corporation Company Details
        11.8.2 AVIVA Biosciences Corporation Business Overview
        11.8.3 AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Introduction
        11.8.4 AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.8.5 AVIVA Biosciences Corporation Recent Developments
    11.9 Precision Therapeutics
        11.9.1 Precision Therapeutics Company Details
        11.9.2 Precision Therapeutics Business Overview
        11.9.3 Precision Therapeutics Non-invasive Cancer Diagnosis Introduction
        11.9.4 Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2017-2022)
        11.9.5 Precision Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Clinical Chemistry
    Table 3. Key Players of Immunochemistry/Immunoassay
    Table 4. Key Players of Molecular Diagnostics
    Table 5. Key Players of Others
    Table 6. Global Non-invasive Cancer Diagnosis Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Non-invasive Cancer Diagnosis Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Non-invasive Cancer Diagnosis Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Non-invasive Cancer Diagnosis Market Share by Region (2017-2022)
    Table 10. Global Non-invasive Cancer Diagnosis Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Non-invasive Cancer Diagnosis Market Share by Region (2023-2028)
    Table 12. Non-invasive Cancer Diagnosis Market Trends
    Table 13. Non-invasive Cancer Diagnosis Market Drivers
    Table 14. Non-invasive Cancer Diagnosis Market Challenges
    Table 15. Non-invasive Cancer Diagnosis Market Restraints
    Table 16. Global Non-invasive Cancer Diagnosis Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Non-invasive Cancer Diagnosis Revenue Share by Players (2017-2022)
    Table 18. Global Top Non-invasive Cancer Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Cancer Diagnosis as of 2021)
    Table 19. Ranking of Global Top Non-invasive Cancer Diagnosis Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Non-invasive Cancer Diagnosis Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Non-invasive Cancer Diagnosis Product Solution and Service
    Table 23. Date of Enter into Non-invasive Cancer Diagnosis Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Non-invasive Cancer Diagnosis Revenue Market Share by Type (2017-2022)
    Table 27. Global Non-invasive Cancer Diagnosis Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Non-invasive Cancer Diagnosis Revenue Market Share by Type (2023-2028)
    Table 29. Global Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Non-invasive Cancer Diagnosis Revenue Share by Application (2017-2022)
    Table 31. Global Non-invasive Cancer Diagnosis Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Non-invasive Cancer Diagnosis Revenue Share by Application (2023-2028)
    Table 33. North America Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Non-invasive Cancer Diagnosis Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Non-invasive Cancer Diagnosis Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Non-invasive Cancer Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Non-invasive Cancer Diagnosis Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Non-invasive Cancer Diagnosis Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Non-invasive Cancer Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Non-invasive Cancer Diagnosis Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Non-invasive Cancer Diagnosis Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Non-invasive Cancer Diagnosis Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Non-invasive Cancer Diagnosis Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Non-invasive Cancer Diagnosis Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Non-invasive Cancer Diagnosis Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Non-invasive Cancer Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Non-invasive Cancer Diagnosis Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Non-invasive Cancer Diagnosis Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Non-invasive Cancer Diagnosis Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Non-invasive Cancer Diagnosis Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Non-invasive Cancer Diagnosis Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Non-invasive Cancer Diagnosis Market Size by Country (2023-2028) & (US$ Million)
    Table 63. Gen-Probe Inc. Company Details
    Table 64. Gen-Probe Inc. Business Overview
    Table 65. Gen-Probe Inc. Non-invasive Cancer Diagnosis Product
    Table 66. Gen-Probe Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 67. Gen-Probe Inc. Recent Developments
    Table 68. A&G Pharmaceutical Company Details
    Table 69. A&G Pharmaceutical Business Overview
    Table 70. A&G Pharmaceutical Non-invasive Cancer Diagnosis Product
    Table 71. A&G Pharmaceutical Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 72. A&G Pharmaceutical Recent Developments
    Table 73. Affymetrix Inc. Company Details
    Table 74. Affymetrix Inc. Business Overview
    Table 75. Affymetrix Inc. Non-invasive Cancer Diagnosis Product
    Table 76. Affymetrix Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 77. Affymetrix Inc. Recent Developments
    Table 78. Digene Corporation Company Details
    Table 79. Digene Corporation Business Overview
    Table 80. Digene Corporation Non-invasive Cancer Diagnosis Product
    Table 81. Digene Corporation Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 82. Digene Corporation Recent Developments
    Table 83. Quest Diagnostics Inc. Company Details
    Table 84. Quest Diagnostics Inc. Business Overview
    Table 85. Quest Diagnostics Inc. Non-invasive Cancer Diagnosis Product
    Table 86. Quest Diagnostics Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 87. Quest Diagnostics Inc. Recent Developments
    Table 88. BioView Inc. Company Details
    Table 89. BioView Inc. Business Overview
    Table 90. BioView Inc. Non-invasive Cancer Diagnosis Product
    Table 91. BioView Inc. Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 92. BioView Inc. Recent Developments
    Table 93. LabCorp Company Details
    Table 94. LabCorp Business Overview
    Table 95. LabCorp Non-invasive Cancer Diagnosis Product
    Table 96. LabCorp Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 97. LabCorp Recent Developments
    Table 98. AVIVA Biosciences Corporation Company Details
    Table 99. AVIVA Biosciences Corporation Business Overview
    Table 100. AVIVA Biosciences Corporation Non-invasive Cancer Diagnosis Product
    Table 101. AVIVA Biosciences Corporation Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 102. AVIVA Biosciences Corporation Recent Developments
    Table 103. Precision Therapeutics Company Details
    Table 104. Precision Therapeutics Business Overview
    Table 105. Precision Therapeutics Non-invasive Cancer Diagnosis Product
    Table 106. Precision Therapeutics Revenue in Non-invasive Cancer Diagnosis Business (2017-2022) & (US$ Million)
    Table 107. Precision Therapeutics Recent Developments
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-invasive Cancer Diagnosis Market Share by Type: 2021 VS 2028
    Figure 2. Clinical Chemistry Features
    Figure 3. Immunochemistry/Immunoassay Features
    Figure 4. Molecular Diagnostics Features
    Figure 5. Others Features
    Figure 6. Global Non-invasive Cancer Diagnosis Market Share by Application: 2021 VS 2028
    Figure 7. Blood Cancer Case Studies
    Figure 8. Solid Tumors Case Studies
    Figure 9. Breast Cancer Case Studies
    Figure 10. Lung Cancer Case Studies
    Figure 11. Others Case Studies
    Figure 12. Non-invasive Cancer Diagnosis Report Years Considered
    Figure 13. Global Non-invasive Cancer Diagnosis Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 14. Global Non-invasive Cancer Diagnosis Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 15. Global Non-invasive Cancer Diagnosis Market Share by Region: 2021 VS 2028
    Figure 16. Global Non-invasive Cancer Diagnosis Market Share by Players in 2021
    Figure 17. Global Top Non-invasive Cancer Diagnosis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Cancer Diagnosis as of 2021)
    Figure 18. The Top 10 and 5 Players Market Share by Non-invasive Cancer Diagnosis Revenue in 2021
    Figure 19. North America Non-invasive Cancer Diagnosis Market Size YoY (2017-2028) & (US$ Million)
    Figure 20. North America Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2028)
    Figure 21. North America Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2028)
    Figure 22. North America Non-invasive Cancer Diagnosis Market Size Share by Country (2017-2028)
    Figure 23. United States Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Canada Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Non-invasive Cancer Diagnosis Market Size YoY (2017-2028) & (US$ Million)
    Figure 26. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2028)
    Figure 27. Europe Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2028)
    Figure 28. Europe Non-invasive Cancer Diagnosis Market Size Share by Country (2017-2028)
    Figure 29. Germany Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. France Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. U.K. Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Italy Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Russia Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Nordic Countries Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Asia-Pacific Non-invasive Cancer Diagnosis Market Size YoY (2017-2028) & (US$ Million)
    Figure 36. Asia Pacific Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2028)
    Figure 37. Asia Pacific Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2028)
    Figure 38. Asia Pacific Non-invasive Cancer Diagnosis Market Size Share by Region (2017-2028)
    Figure 39. China Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Japan Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. South Korea Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Southeast Asia Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. India Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Australia Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 45. Latin America Non-invasive Cancer Diagnosis Market Size YoY (2017-2028) & (US$ Million)
    Figure 46. Latin America Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2028)
    Figure 47. Latin America Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2028)
    Figure 48. Latin America Non-invasive Cancer Diagnosis Market Size Share by Country (2017-2028)
    Figure 49. Mexico Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 50. Brazil Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Non-invasive Cancer Diagnosis Market Size YoY (2017-2028) & (US$ Million)
    Figure 52. Middle East and Africa Non-invasive Cancer Diagnosis Market Size Market Share by Type (2017-2028)
    Figure 53. Middle East and Africa Non-invasive Cancer Diagnosis Market Size Market Share by Application (2017-2028)
    Figure 54. Middle East and Africa Non-invasive Cancer Diagnosis Market Size Share by Country (2017-2028)
    Figure 55. Turkey Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Saudi Arabia Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. UAE Non-invasive Cancer Diagnosis Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. Gen-Probe Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 59. A&G Pharmaceutical Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 60. Affymetrix Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 61. Digene Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 62. Quest Diagnostics Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 63. BioView Inc. Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 64. LabCorp Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 65. AVIVA Biosciences Corporation Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 66. Precision Therapeutics Revenue Growth Rate in Non-invasive Cancer Diagnosis Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Gen-Probe Inc.
A&G Pharmaceutical
Affymetrix Inc.
Digene Corporation
Quest Diagnostics Inc.
BioView Inc.
LabCorp
AVIVA Biosciences Corporation
Precision Therapeutics
Frequently Asked Questions
Non-invasive Cancer Diagnosis report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-invasive Cancer Diagnosis report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-invasive Cancer Diagnosis report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

R-125 Refrigerant

R-125 Refrigerant market is segmented by Type and by Application. Players, stakeholders, and othe ... Read More